TMB-365 and TMB-380 in Suppressed HIV-1 Infected Individuals
NCT05275998
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
51
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV-1-infection
Interventions
DRUG:
TMB-365/TMB-380
Sponsor
TaiMed Biologics Inc.